Max Healthcare Institute Limited has informed the Exchange regarding Change in Director(s) of the company.
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Max Healthcare approved its Q4 and FY2026 audited financial results showing strong growth. Consolidated revenue from operations grew 19.1% to ₹8,373 crore, while profit after tax rose 34.1% to ₹1,442 crore. Basic EPS for FY2026 stood at ₹14.83. The Board recommended a dividend of ₹2 per share (20% face value). Key corporate actions include approval for reclassifying Radiant Life Care Hospital Foundation from Promoter Group to Public category, construction of a new 712-bed hospital in Lucknow, and shifting the registered office from Mumbai to Gurugram. Mr. Anil Kumar Bhatnagar was reappointed as Non-Executive Non-Independent Director for 3 years. S.R. Batliboi & Co. LLP issued an unmodified opinion on the financial statements.
Strong financial performance with ~34% PAT growth and shareholder-friendly dividend signals healthy fundamentals. The re-classification of promoter entity may slightly alter shareholding structure, while the new Lucknow hospital and Gurugram relocation indicate expansion plans in North India.